Concomitant Infection of Intestinal Parasites and Helicobacter Pylori

Concomitant Infection of Intestinal Parasites and Helicobacter Pylori in Sohag University Hospital

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05360940

Enrollment

200

Registered

2022-05-04

Start date

2022-09-30

Completion date

2023-07-31

Last updated

2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia Abdominal Burning Pain Diarrhea Dysentery

Keywords

Helicobacter pylori Intestinal Parasites

Brief summary

Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in the world especially in developing countries. Helicobacter pylori is a gram-negative,helical-shaped,motile bacillus bacterium,which colonizes the gastric mucosa. H.pylori bacterium secretes urease,a special enzyme that converts urea to ammonia. Ammonia reduces the stomach's acidity .This risk factor allows pathogenic intestinal protozoa such as G.lamblia to take the opportunity to cross through the stomach's increased pH and cause disease.

Interventions

DIAGNOSTIC_TESTH.pylori stool antigen rapid test and stool parasitological examination

200 stool samples ( 100 positive and 100 negative for H.pylori) after performance of H.pylori stool rapid antigen test then parasitological stool examination will be done

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* patients complaining of dyspepsia , abdominal burning pain,diarrhea,dysentery,of persons of any age or sex group.

Exclusion criteria

* patients taking antibiotics within the previous four weeks, proton pump inhibitors within the previous two weeks, or anti-parasitic drugs within the previous two weeks.

Design outcomes

Primary

Measure	Time frame	Description
Compare the prevalence of intestinal parasitic infections among positive and negative H.pylori infected outpatients in Sohag University Hospital	18 weeks following the start point of the study	Collection of 200 stool samples (100 positive and 100 negative for H.pylori) then parasitological examination done for all samples

Secondary

Measure	Time frame	Description
Evaluate the prevalence of intestinal parasitic infection among H.pylori infected outpatients in Sohag University Hospital	18 weeks following the start point of the study	Macroscopic and microscopic examination of 100 positive H.pylori stool samples

Countries

Egypt

Contacts

Primary ContactAsmaa Nabil Abouzeid

asmaanabil@med.sohag.edu.eg01144306719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026